Recruiting Type 1 Diabetes Studies in Palo Alto
About Type 1 Diabetes Clinical Trials in Palo Alto
Type 1 diabetes is an autoimmune condition where the immune system destroys insulin-producing beta cells in the pancreas. It typically develops in childhood or young adulthood and requires lifelong insulin therapy. Research is exploring artificial pancreas systems, immunotherapy, and beta cell replacement.
There are currently 1 type 1 diabetes clinical trials recruiting participants in Palo Alto, CA. These studies are seeking a combined 1,500 participants. Research is being sponsored by Medtronic MiniMed, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Type 1 Diabetes Clinical Trials in Palo Alto — FAQ
Are there type 1 diabetes clinical trials in Palo Alto?
Yes, there are 1 type 1 diabetes clinical trials currently recruiting in Palo Alto, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Palo Alto?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Palo Alto research site will contact you about next steps.
Are clinical trials in Palo Alto free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Palo Alto studies also compensate for your time and travel.
What type 1 diabetes treatments are being tested?
The 1 active trials in Palo Alto are testing new therapies including novel drugs, biologics, and treatment approaches for type 1 diabetes.
Data updated October 12, 2026 from ClinicalTrials.gov